Rallybio (RLYB) Stock Statistics & Valuation Metrics

Rallybio has a market cap or net worth of $19.57M. The enterprise value is $2.57M.

Rallybio has 41,613,964 shares outstanding. The number of shares has decreased by -2.65% in one year.

Rallybio’s return on equity (ROE) is -0.94 and return on invested capital (ROIC) is -93.76%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Rallybio had revenue of 636.00K and earned -57.77M in profits. Earnings per share was -1.33.

In the last 12 months, operating cash flow was -44.03M and capital expenditures 0.00, giving a free cash flow of -44.03M billion.

Rallybio pays an annual dividend of ―, resulting in a dividend yield of ―

Rallybio upcoming earnings date is Aug 6, 2025, Before Open (Confirmed).

Rallybio as a current ratio of 10.87, with Debt / Equity ratio of 0.21%

In the past 12 months, Rallybio has paid -2.24M in taxes.

Rallybio EV to EBITDA ratio is -0.46, with an EV/FCF ratio of -0.57.

Rallybio has $54.49M in cash and marketable securities with $116.00K in debt, giving a net cash position of -$54.38M billion.

Gross margin is 92.45%, with operating margin of -9511.95%, and net profit margin of -9084.12%.

The average price target for Rallybio is $1.00, which is 11.43% higher than the current price. The consensus rating is Hold